Oxford Biomedica plc (OXB.L)
GBp 295.0
(0.0%)
GBp 295.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -184.17 Million GBP | -73.37% |
| 2022 | -51.55 Million GBP | -348.26% |
| 2021 | 20.76 Million GBP | 530.07% |
| 2020 | -4.82 Million GBP | 61.63% |
| 2019 | -12.58 Million GBP | -257.24% |
| 2018 | 8 Million GBP | 241.2% |
| 2017 | -5.66 Million GBP | 49.9% |
| 2016 | -11.31 Million GBP | 19.67% |
| 2015 | -14.08 Million GBP | -32.7% |
| 2014 | -10.61 Million GBP | 17.23% |
| 2013 | -12.82 Million GBP | -22.28% |
| 2012 | -10.48 Million GBP | -14.6% |
| 2011 | -9.15 Million GBP | -176.19% |
| 2010 | 12.01 Million GBP | 109.62% |
| 2009 | 5.73 Million GBP | -58.09% |
| 2008 | 13.67 Million GBP | -31.05% |
| 2007 | 19.82 Million GBP | -6.04% |
| 2006 | 21.1 Million GBP | 87.86% |
| 2005 | 11.23 Million GBP | -10.18% |
| 2004 | 12.5 Million GBP | -1.15% |
| 2003 | 12.65 Million GBP | -9.74% |
| 2002 | 14.01 Million GBP | 27.12% |
| 2001 | 11.02 Million GBP | 85.76% |
| 2000 | 5.93 Million GBP | 234.76% |
| 1999 | -4.4 Million GBP | -211.69% |
| 1998 | 3.94 Million GBP | 0.0% |
| 1997 | - GBP | -100.0% |
| 1996 | 88 Thousand GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -32.23 Million GBP | 0.0% |
| 2023 FY | -89.38 Million GBP | -73.37% |
| 2023 Q2 | -52.63 Million GBP | 0.0% |
| 2023 Q4 | -133.42 Million GBP | 0.0% |
| 2022 Q2 | -20.04 Million GBP | 0.0% |
| 2022 FY | -51.55 Million GBP | -348.26% |
| 2022 Q4 | -33.82 Million GBP | 0.0% |
| 2021 FY | 20.76 Million GBP | 530.07% |
| 2021 Q2 | 19.21 Million GBP | 0.0% |
| 2021 Q4 | 850 Thousand GBP | 0.0% |
| 2020 Q2 | -5.39 Million GBP | 0.0% |
| 2020 FY | -4.82 Million GBP | 61.63% |
| 2020 Q4 | -268 Thousand GBP | 0.0% |
| 2019 FY | -12.58 Million GBP | -257.24% |
| 2019 Q2 | -5.35 Million GBP | 0.0% |
| 2019 Q4 | -8.1 Million GBP | 0.0% |
| 2018 Q4 | -1.45 Million GBP | 0.0% |
| 2018 FY | 8 Million GBP | 241.2% |
| 2018 Q2 | 9.38 Million GBP | 0.0% |
| 2017 Q2 | -4.51 Million GBP | 0.0% |
| 2017 FY | -5.66 Million GBP | 49.9% |
| 2017 Q4 | -3.44 Million GBP | 0.0% |
| 2016 Q4 | -4.37 Million GBP | 0.0% |
| 2016 FY | -11.31 Million GBP | 19.67% |
| 2016 Q2 | -6.94 Million GBP | 0.0% |
| 2015 Q2 | -8.27 Million GBP | 0.0% |
| 2015 Q4 | -5.81 Million GBP | 0.0% |
| 2015 FY | -14.08 Million GBP | -32.7% |
| 2014 Q4 | -5.19 Million GBP | 0.0% |
| 2014 FY | -10.61 Million GBP | 17.23% |
| 2014 Q2 | -5.41 Million GBP | 0.0% |
| 2013 Q4 | -6.08 Million GBP | 0.0% |
| 2013 FY | -12.82 Million GBP | -22.28% |
| 2013 Q2 | -6.73 Million GBP | 0.0% |
| 2012 FY | -10.48 Million GBP | -14.6% |
| 2012 Q2 | - GBP | 0.0% |
| 2012 Q4 | - GBP | 0.0% |
| 2011 FY | -9.15 Million GBP | -176.19% |
| 2011 Q4 | - GBP | 0.0% |
| 2011 Q2 | - GBP | 0.0% |
| 2010 Q4 | - GBP | 0.0% |
| 2010 FY | 12.01 Million GBP | 109.62% |
| 2010 Q2 | - GBP | 0.0% |
| 2009 Q4 | - GBP | 0.0% |
| 2009 FY | 5.73 Million GBP | -58.09% |
| 2009 Q2 | - GBP | 0.0% |
| 2008 Q4 | - GBP | 0.0% |
| 2008 FY | 13.67 Million GBP | -31.05% |
| 2008 Q2 | - GBP | 0.0% |
| 2007 Q4 | - GBP | 0.0% |
| 2007 FY | 19.82 Million GBP | -6.04% |
| 2007 Q2 | - GBP | 0.0% |
| 2006 FY | 21.1 Million GBP | 87.86% |
| 2006 Q4 | - GBP | 0.0% |
| 2006 Q2 | - GBP | 0.0% |
| 2005 Q2 | - GBP | 0.0% |
| 2005 Q4 | - GBP | 0.0% |
| 2005 FY | 11.23 Million GBP | -10.18% |
| 2004 Q2 | - GBP | 0.0% |
| 2004 FY | 12.5 Million GBP | -1.15% |
| 2004 Q4 | - GBP | 0.0% |
| 2003 Q2 | - GBP | 0.0% |
| 2003 FY | 12.65 Million GBP | -9.74% |
| 2003 Q4 | - GBP | 0.0% |
| 2002 FY | 14.01 Million GBP | 27.12% |
| 2002 Q4 | - GBP | 0.0% |
| 2002 Q2 | - GBP | 0.0% |
| 2001 FY | 11.02 Million GBP | 85.76% |
| 2000 FY | 5.93 Million GBP | 234.76% |
| 1999 FY | -4.4 Million GBP | -211.69% |
| 1998 FY | 3.94 Million GBP | 0.0% |
| 1997 FY | - GBP | -100.0% |
| 1996 FY | 88 Thousand GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|